glp-1 compounding news november 2025 FDA takes aim at telehealth companies for promoting unofficial weight loss drug dupes Did the FDA Ban Compounded

Our Take Perimenopause isn't just "a phase", it's a full-system shift

Qsymia is FDA-approved as a weight loss drug for adults with a BMI of 30 or greater, or a BMI of 27 or greater and a weight-related health condition

Participants were randomly assigned, 1:1:1, to once-weekly combination cagrilintide and semaglutide 2.4 mg, once-weekly semaglutide 2.4 mg plus placebo or once-weekly cagrilintide 2.4 mg plus placebo

Semaglutide may cost about $900$1,200 per month

A comparison of our methodology and previously published assays has been presented in Tables 3 and 4

1 After cleansing and toning, apply a thin, even layer over the face